Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Early Lymphedema Detection

Research Leaders

6 sponsors active, led by Tom Baker Cancer Centre

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
Phase 3 (1)

Trial Status

Unknown2
Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Early Lymphedema Detection1
  • Lymphaticovenous Anastomosis Using Microsure Motion Stabilizer1
  • Monterey Pneumatic Compression Device1
  • Lymphaticovenous Anastomosis Manual1
  • Prophylactic Lymphaticonvenous Anastomosis1

Active Sponsors

  • Tom Baker Cancer Centre1
  • ResMed1
  • University of Calgary1
  • Alberta Health Services, Calgary1
  • Hospital Donostia1

Top Investigators

Related Conditions

  • Lymphedema Secondary1
  • Sentinel Lymph Node1
  • Lymphedema Breast Cancer1
  • Lymphedema1
  • Lymphedema Nonfilarial1

Activity Timeline